Valeo Pharma Inc.
VPHIF · OTC
10/31/2023 | 10/31/2022 | 10/31/2021 | 10/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $8 | $23 | $2 | $3 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $7 | $5 | $1 | $1 |
| Inventory | $10 | $10 | $8 | $1 |
| Other Curr. Assets | $1 | $3 | $1 | $1 |
| Total Curr. Assets | $25 | $41 | $12 | $5 |
| Property Plant & Equip (Net) | $3 | $2 | $2 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $12 | $15 | $7 | $5 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $0 | $0 | $0 |
| Total NC Assets | $16 | $18 | $9 | $6 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $41 | $58 | $21 | $11 |
| Liabilities | – | – | – | – |
| Payables | $4 | $4 | $7 | $3 |
| Short-Term Debt | $5 | $1 | $5 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $11 | $0 | $0 |
| Other Curr. Liab. | $12 | $0 | $3 | $1 |
| Total Curr. Liab. | $20 | $15 | $15 | $4 |
| LT Debt | $60 | $61 | $3 | $3 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $0 | $1 | $0 |
| Total NC Liab. | $61 | $61 | $4 | $4 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $1 | $0 |
| Total Liabilities | $82 | $76 | $19 | $8 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $32 | $26 | $25 | $15 |
| Retained Earnings | -$82 | -$54 | -$29 | -$14 |
| AOCI | -$0 | -$0 | -$0 | -$0 |
| Other Equity | $11 | $10 | $6 | $3 |
| Total Equity | -$40 | -$18 | $2 | $3 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $41 | $58 | $21 | $11 |
| Net Debt | $58 | $39 | $6 | $0 |